Skip Navigation


NDT Advance Access originally published online on September 11, 2008
Nephrology Dialysis Transplantation 2009 24(2):483-488; doi:10.1093/ndt/gfn513
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/2/483    most recent
gfn513v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by L. Weber, C.
Right arrow Articles by Magil, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by L. Weber, C.
Right arrow Articles by Magil, A. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study

Catherine L. Weber1, Caren L. Rose1 and Alex B. Magil2

1 Division of Nephrology, Department of Medicine, University of British Columbia 2 Department of Pathology and Laboratory Medicine, St Paul's Hospital, Vancouver, British Columbia, Canada

Correspondence and offprint requests to: Alexander B. Magil, Department of Pathology and Laboratory Medicine, St Paul's Hospital, 1081 Burrard Street, Vancouver, British Columbia V6Z 1Y6, Canada. Tel: +1-604-806-8700; Fax: +1-604-806-8701; E-mail: amagil{at}providencehealth.bc.ca



  Abstract

Background. The significance of focal segmental glomerulosclerosis (FSGS) in mild IgA nephropathy is uncertain.

Methods. All consecutive renal biopsies performed between 1996 and 2005 in adults with a diagnosis of mild IgA nephropathy (Lee Grade 1 or 2) at St Paul's Hospital, Vancouver, Canada, were reviewed.

Results. Seventy-five patients were included, 26 (35%) with IgA nephropathy and FSGS (FSGS+ group) and 49 (65%) with IgA nephropathy without FSGS (FSGS– group). The mean follow-up was 3 years. At the time of renal biopsy the FSGS+ group had a lower eGFR (60 versus 73 mL/min, P = 0.02), lower serum albumin (38 versus 41 g/L, P = 0.02), higher mean arterial pressure (103 versus 97 mmHg, P = 0.03) and greater protein excretion (3.0 versus 1.3 g/day, P < 0.01) than the FSGS– group. On histology, the FSGS+ group had a higher percentage of obsolete glomeruli (23.4% versus 12.7%, P < 0.01), and 31% of FSGS+ biopsies had ≥25% tubular atrophy/interstitial fibrosis while this was not observed in the FSGS– group (P < 0.01). The primary outcome measure, {Delta}GFR, was –2.56 mL/ min/year in the FSGS+ group and +1.14 mL/min/year in the FSGS– group, difference: 3.70 mL/min/year (P = 0.03) (univariate). In the multivariate model, the FSGS+ group declined at 0.19 mL/min/year (–14.16, 13.78) and the FSGS– group improved at 2.85 mL/min/year (–11.64, 17.34), difference 3.04 mL/min/year, P = 0.18.

Conclusions. Our study suggests that the focal segmental glomerulosclerosis lesion and associated clinical and pathologic findings in patients with mild IgA nephropathy are associated with a worse renal outcome.

Keywords: focal segmental glomerulosclerosis; glomerular filtration rate; IgA nephropathy; outcomes

Received for publication: 11. 4.08
Accepted in revised form: 20. 8.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.